Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 10;31(3):733-744.
doi: 10.1016/j.numecd.2020.11.028. Epub 2020 Dec 9.

Nutrition in adult patients with selected lysosomal storage diseases

Collaborators, Affiliations
Review

Nutrition in adult patients with selected lysosomal storage diseases

Francesca Carubbi et al. Nutr Metab Cardiovasc Dis. .

Abstract

Lysosomal storage disorders (LSDs) are a group of clinically heterogeneous disorders affecting the function of lysosomes and are characterized by an accumulation of undigested substrates within several cell types. In recent years there have been substantial advances in supportive care and drug treatment for some LSDs, leading to improved patient survival, as seen in Gaucher, Pompe and Fabry disease and some Mucopolysaccharidoses; however, many symptoms still persist. Thus it is now even more important to improve patients' quality of life and reduce symptoms and comorbidities. One potential way of achieving this goal is through adjunct nutritional therapy, which is challenging as patients may be overweight with associated consequences, or malnourished, or underweight. Furthermore, drugs used to treat LSDs can modify the metabolic status and needs of patients. There are currently not enough data to make specific dietary recommendations for individual LSDs; however, suggestions can be made for managing clinical manifestations of the diseases, as well as treatment-associated adverse events. The metabolic and nutritional status of adult patients must be regularly assessed and individualized dietary plans may be created to cater to a patient's specific needs. Damage to the autophagic process is a common feature in LSDs that is potentially sensitive to dietary manipulation and needs to be assessed in clinical studies.

Keywords: Dietary modifications; Lysosomal storage disorders; Nutrition therapy; Recommendations.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Francesca Carubbi received honoraria for lectures, advisory board and meetings from Amgen, Sanofi, Shire and Amicus. Francesco Francini-Pesenti received honoraria for advisory boards and meetings from Sanofi. Elena Pegoraro has been a scientific advisory board or data safety monitoring board for PTC Therapeutics, Sarepta Therapeutics, Santhera Pharmaceuticals, Genzyme and Roche, received funding for travel and educational support from Genzyme and PTC Pharmaceuticals, received funding for travel support from Santhera and is receiving grant support from Santhera. Antonio Barbato received honoraria for lectures, advisory boards and meetings from Sanofi Genzyme and Takeda Shire. Renzo Mignani received honoraria for lectures, advisory boards and meetings from Sanofi-Genzyme, TakedaShire, Otsuka Pharmaceutical, and AmicusTherapeutics. Alberto B Burlina has received a speaker honoraria and travel support from Sanofi Genzyme, Actelion, Takeda, Nutricia, Danone, PIAM Medifood, Biomarin. Linda Landini has been an employee of Sanofi Genzyme. Gianluca De Danieli is an employee of Sanofi Genzyme. Stefano Bruni has been an employee of Sanofi Genzyme. Pasquale Strazzullo received honoraria and travel support as speaker and/or advisory board from Sanofi Genzyme and Takeda Shire.

Publication types

MeSH terms

LinkOut - more resources